Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Five modifiable risk factors are associated with cardiovascular disease and death from any cause. Studies using individual-level data to evaluate the regional and sex-specific prevalence of the risk factors and their effect on these outcomes are lacking. METHODS: We pooled and harmonized individual-level data from 112 cohort studies conducted in 34 countries and 8 geographic regions participating in the Global Cardiovascular Risk Consortium. We examined associations between the risk factors (body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes) and incident cardiovascular disease and death from any cause using Cox regression analyses, stratified according to geographic region, age, and sex. Population-attributable fractions were estimated for the 10-year incidence of cardiovascular disease and 10-year all-cause mortality. RESULTS: Among 1,518,028 participants (54.1% of whom were women) with a median age of 54.4 years, regional variations in the prevalence of the five modifiable risk factors were noted. Incident cardiovascular disease occurred in 80,596 participants during a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants died during a median follow-up of 8.7 years (maximum, 47.6). For all five risk factors combined, the aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% confidence interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men, and the corresponding values for 10-year all-cause mortality were 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6). CONCLUSIONS: Harmonized individual-level data from a global cohort showed that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. (Funded by the German Center for Cardiovascular Research (DZHK); ClinicalTrials.gov number, NCT05466825.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As well as the significant improvement in diabetic control, cardiometabolic risk was also improved by a significant reduction in SBP which was recorded across the cohort, specifically for those who had one or more co-existing medical conditions and for those who had a diagnosis of T2D of less than 6 years29.”
From mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes (2025) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
(2010) · University of Twente Research Information · Cited by 6,037
Auditory and non-auditory effects of noise on health
Basner, M., Babisch, W., Davis, A., Brink, M., Clark, C., Janssen, S., & Stansfeld, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61613-x · Cited by 2,473 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Global burden of blood-pressure-related disease, 2001
Lawes, C. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,330 · cited 3×
“While tobacco consumption is strongly associated with premature mortality, elevated blood pressure and cholesterol are more specifically related to CVD. 7 A tailored reduction in the burden of CVD and all-cause mortality for persons and populations can be achieved with better understanding of the region-and sex-specif…”
InfluentialEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
Cited by
Items 801–900 of 980
Effectiveness of check-up 35 for detecting targeted diseases in Germany
Kommer, A., Weinmann-Menke, J., Kostev, K., & Labenz, C. (2026) · BMC Family Practice · doi:10.1186/s12875-026-03307-4
Ungar, A., Ambrosino, I., Rivasi, G., Ceolin, L., Bellelli, G., Bisconti, E., Catalani, M. C., Cherubini, A., Colombo, L., Contalbrigo, L., et al. (2026) · Aging Clinical and Experimental Research · doi:10.1007/s40520-026-03386-4
Викторовна, А. Е., Гакова, Е. И., Akimov, A. M., Kayumova, M. M., Игоревна, Б. М., & Гафаров, В. В. (2026) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2026-2517
Muzurović, E. M., Zečević, K., & Mikhailidis, D. P. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02367-3
Sport bei arterieller Hypertonie – Evidenz, Leitlinien und Praxis
Bauer, P. (2026) · Aktuelle Kardiologie · doi:10.1055/a-2804-4122
Chenkual, L., Lalchandani, D. S., Sathala, P. K., Mahindran, M., Senapati, A., Divate, M., & Porwal, P. K. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.118067
Asgari, S., Hasanpour, A., Khalili, D., Azizi, F., & Hadaegh, F. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101635
“Cardiovascular disease (CVD) accounts for approximately one-third of all deaths worldwide, with elevated low-density lipoprotein cholesterol (LDL-C) recognized as a major modifiable risk factor [1].”
Huang, Y., Li, Y., Zheng, Y., Wan, P. E. N. G., Ye, Z., 倪同岭, Wang, Z., Lin, Z., Hu, J., 關浩, 和., et al. (2026) · Global Transitions · doi:10.1016/j.glt.2026.04.001
Schaefer, G. J. L., & Saritas, T. (2026) · Nephrologie aktuell · doi:10.1055/a-2749-2368
Shirazi, S. A. R., Khan, R., Akhtar, R., Siddiqa, S., Yousaf, N., & Abbas, A. W. (2026) · VAWKUM Transactions on Computer Sciences · doi:10.21015/vtcs.v14i1.2333
Abdennadher, B., Goßling, A., Kellner, C., Koschwitz, J., Paasch, L., Sörensen, N. A., Zeller, T., Twerenbold, R., Blankenberg, S., Sinning, C., et al. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.03.071
Chen, S., Ji, Y., Yang, R., Peng, X., Bai, J., Fan, X., Song, Q., & Cai, J. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.04.005
Rojas, A. P., Calderón, A., Dhanasekaran, M., Shakil, J., & Patham, B. (2026) · Nutrients · doi:10.3390/nu18091344
Pinheiro, N. C. T., Júnior, J. A. D. S. M., Leão, J. P. S., Nunes, V. L. M., Paulucio, D. S. S., Rodrigues, I. C., de Alcantara, N. L., Frazão, L. D. C., do Rego, E. L., Maia, A. L. B., et al. (2026) · Revista Científica Brasileira de Saúde e Medicina (Brazilian Scientific Journal of Health and Medicine) · doi:10.51473/rbmed.v1i1.2026.22
Leontyeva, I. V. (2026) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2026-71-2-7-17
Ma, C., Zhao, D., Huo, R., & Liu, Y.-H. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.108967
de Avelar, M. H. M., Pires, C. V., Silva, C. E. S. E., Silva, A. P. C. M., Silva, W. A., Gonçalves, A. C. A., Rodrigues, C. G., Kobori, C. N., & Carlos, L. D. A. (2026) · Journal of Food Processing and Preservation · doi:10.1155/jfpp/9734407
Rosses, A. P. O., Marques, G. Á., da Silva, B. G. C., MENEZES, A. M. B., Gonçalves, H., Hartwig, F. P., Horta, B., & Wehrmeister, F. C. (2026) · Cadernos de Saúde Pública · doi:10.1590/0102-311xpt178025
Rosses, A. P. O., Marques, G. Á., da Silva, B. G. C., MENEZES, A. M. B., Gonçalves, H., Hartwig, F. P., Horta, B., & Wehrmeister, F. C. (2026) · Cadernos de Saúde Pública · doi:10.1590/0102-311xen178025
“Cardiometabolic diseases have been the leading cause of global mortality since the 1940s and currently account for approximately one-third of deaths throughout the world 1,2,3 , corresponding to about 20 million deaths per year, 80% of which occur in low-and middle-income countries 4 .”
Kaliumsubstitution – ist der Ersatz von natrium- durch kaliumhaltige Speisesalze sinnvoll?
Götzinger, F., Kunz, M., Lauder, L., & Mahfoud, F. (2026) · Die Innere Medizin · doi:10.1007/s00108-026-02112-6
Chen, S. M., Han, K., Wang, S., Yang, S., Shi, Y. T., Wang, W., Du, S., Ye, X., Wan, Y., Wang, J., et al. (2026) · npj Aging · doi:10.1038/s41514-026-00393-7
Ogyu, A., Rouzier, V., Sufra, R., Sauveur, R. S., Celestin, K., Forestal, G. P. L., Préval, F., Marcelin, S. E., Auguste, S., Lee, M. H., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26295
Sari, R. E., Syukri, M., Putra, A. N., & Halim, R. (2026) · SEHATMAS Jurnal Ilmiah Kesehatan Masyarakat · doi:10.55123/sehatmas.v5i2.7877
Waßmann, S. (2026) · Die Innere Medizin · doi:10.1007/s00108-026-02118-0
Zhuang, M., Peng, X., Song, Q., Bai, J., Yu, M., & Cai, J. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004118
“[1,2] Individuals with hypertension are at an increased risk of multiple comorbidities, including cardiovascular disease and renal dysfunction.”
Butler, M. J., Lobosco, D., Miller, D., Honcharuk, E. M., Cheung, Y. K., & Goodwin, A. M. (2026) · Exploration of Medicine · doi:10.37349/emed.2026.1001402
Fosse, G. Ø., Huber, S., Grimnes, G., Leon, D. A., Brox, J. H., Jorde, R., Bjørke‐Monsen, A., Eggen, A. E., & Averina, M. (2026) · Environmental Research · doi:10.1016/j.envres.2026.124705
Low‐Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial
Ahn, H., Ahn, J., Cho, J., Lim, K. H., Han, S. H., Cho, Y., Kim, K. H., Hong, S. J., Lee, C. J., Na, J. O., et al. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70279
Sex Differences in Exercise-Induced Arteriolar Remodeling of Skeletal Muscle
Hainzl, T., Nádasy, G. L., Márka, E. R., Nagy, K., Tõkés, A., Oláh, A., Radovits, T., Merkely, B. P., Ács, N., Várbíró, S., et al. (2026) · Applied Sciences · doi:10.3390/app16105041
Psychosoziale und medizinische Dimensionen der Therapieadhärenz
Köditz, A., & Ernst, J. (2026) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/a-2598-2093
Rodilla, E., Iriarte, O. A., Serrano, B. M., Ruilope, L. M., Sedano-Gil, G., Ortiz, A., Costa-Muñoz, J.-A., Ribelles, J. C., Zabalza-Zudaire, M., & Sayar, O. (2026) · PLOS Digital Health · doi:10.1371/journal.pdig.0001441
Masrouri, S., Ebrahimi, N., Molavizadeh, D., Esmaeili, F., Azizi, F., & Hadaegh, F. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104805
The interplay of genetics and modifiable risk in atherosclerosis
Schunkert, H. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120727
Badimón, L., Vilahur, G., & Mendieta, G. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120777
The Male Survival Disadvantage
Krumholz, H. M. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.04.018
Song, J., Liu, Y., Shang, Q., Liu, J., Zhang, H., Zhou, Z., Wang, W., Lu, J., & Zheng, X. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.14858
Simeunovic, A., Brunborg, C., Heier, M., Berg, T. J., Dahl‐Jørgensen, K., & Margeirsdottir, H. D. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004338
“Recently, the Global Cardiovascular Risk Consortium har-monized > pressure (SBP) is the most important modifiable risk factor for CVD in the general population [3].”
Obianyido, O., Obianyido, H., Okwor, J. C., Ikekpeazu, V., Onwasigwe, C., Okechukwu, U., & Je, I. (2026) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_696_25
Haynes, A., Mynard, J. P., van der Veen, M., Carson, J., & GREEN, D. J. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.90273.2026
Tiruneh, Y. M., McBride, S., Song, H., Decaro, M., Rihan, A., Byrd, T. L., Baham, A., Magnani, J. W., Bernstam, E. V., & Berry, J. D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15114233
“Hypertension, a leading yet modifiable CVD risk factor, largely drives this gap [8–10].”
Alsarraf, A., Awan, Z. A., Baghal, O., Bayeh, H., Chaaban, S. M., Jammal, M. T., Kassab, R., Abdelmassih, T., Okkeh, O., Ray, K. K., et al. (2026) · Cureus · doi:10.7759/cureus.110155
Lipid-lowering therapy after finding high Lp(a)—adding ezetimibe or intensifying statin treatment?
Vuorio, A. F., Kovanen, P. T., & Raal, F. J. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.06.001
Sjöström, A., Hörnsten, Å., Wennberg, P., Lundberg, T., & Almevall, A. D. (2026) · BMC Family Practice · doi:10.1186/s12875-026-03401-7
Starnecker, F., Krefting, J., Nissen, L., Schwab, M., Jovanović, M., Najem, S. A., von Scheidt, M., Jonas, S., Schunkert, H., & Reimer, L. M. (2026) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-026-00806-4
The impact of cardiovascular risk factors in non-classical Fabry disease
Veldman, B. C. F., van Dussen, L., Datema, M. R., Meinsma, R., Meijer, J., Koster, J., Kuilenburg, A. B. P., Janssens, M., Robbers, L. F. H. J., & Langeveld, M. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04425-z
Modifiable risk factors for cardiovascular diseases in aviation and prospects for their correction
Евгеньевна, А. Е., Борисовна, З. Н., Потиевский, Б. Г., Bushmanov, A. Y., & Dorofeev, A. V. (2026) · Science and Innovations in Medicine · doi:10.35693/sim704255
Wu, L., Long, Y., Zou, X., Ren, L., & Fang, K. (2026) · Medicine · doi:10.1097/md.0000000000049109
“3] In China, the prevalence of CMDs has risen rapidly in recent decades, with over 330 million people affected, and an age-standardized prevalence of 23.2% nationwide.”
InfluentialIhle-Hansen, H., Bratholm, Å. O., Hagberg, G., Berge, T., Omland, T., Røsjø, H., Tveit, A., Rønningen, P. S., Lyngbakken, M. N., & Ihle-Hansen, H. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag308
Rethinking cardiovascular prevention in the era of artificial intelligence
Sniderman, A. D., & Pencina, M. J. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag317
Clinical analysis of drug treatment trends for coronary heart disease in China
Li, X., Lou, J., Li, X., Li, S., Gu, J., Zhang, D., Luo, Z., Cao, J., & 谢杰斌 (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1809277
Naeem, K., Rizvi, F., & Ahmad, H. M. I. (2026) · Pakistan Journal of Public Health · doi:10.32413/pjph.v16i1.1594
Pedroza, J. A., Serpas, D. G., García, J. J., Zelaya, D. G., Alcala, M. S., & Keys, K. (2026) · LGBT Health · doi:10.1177/23258292261452696
An efficient hybrid approach for classifying cardiovascular disease risks DenseNet and MobileNet
Valasapalli, M., & Sai, N. R. (2026) · International Journal of Systems Assurance Engineering and Management · doi:10.1007/s13198-026-03369-8
Navarro, O. D., Copete, S., Moreno-Martínez, A., & Blanco-Marchite, C. (2026) · European Journal of Ophthalmology · doi:10.1177/11206721261461913
Precision modification of heart failure signaling by CRISPR-Cas9 base editing
Tadokoro, T., Liu, N., & Olson, E. N. (2026) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2026.06.008
“Cardiovascular disease accounts for approximately one-third of all deaths worldwide [1].”
Targeting disease activity to predict and prevent damage in obstructive airway diseases
Pavord, I. D. (2026) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2026.06.017
Apinis, P., Bajāre, I., Dzērve, V., Jēgere, S., Tzivian, L., Kokina, B., Luguzis, A., Čakša, A., & Ērglis, A. (2026) · Medicina · doi:10.3390/medicina62061201
Al-Qudimi, T. A. A. H., & Al-Yahawi, A. A. (2026) · Health Dynamics · doi:10.33846/hd30505
The Need for Community-Based Multimodal Screening for Chronic Disease and Cancer in Rural Kansas
Neely, J. A., Schmidt, J. R., Ziaei, E. S., Elliott, K. G., Durrett, R. D., McMann, L., & Ventura, C. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s613943
Ausserwinkler, M., Jung, C., Paulweber, B., Bauer, J., Kedenko, L., Kiesslich, T., Fixl, B., Trinka, E., Langthaler, P. B., Iglseder, B., et al. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02974-8
Depletion of Blautia wexlerae and Parabacteroides distasonis in adiposity-related prehypertension
Luo, L., Cheng, K., Chen, B., Li, Y., Ruan, L., Li, Z., Zhu, S., Zhao, L., Zhang, C., Liu, Y., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1873803
Rospleszcz, S., Ittermann, T., Woeckel, M., Schipf, S., Schuppert, C., Storz, C., Lorbeer, R., Bülow, R., Dörr, M., Felix, S. B., et al. (2026) · medRxiv · doi:10.64898/2026.06.29.26356804
Parmar, R. B., Eldawud, D., & Budzikowski, A. (2026) · BMJ Innovations · doi:10.1136/bmjinnov-2026-001575
Lan, X., Wu, Q., Zhou, J., Jiang, J., Yang, G., Yang, H., Chen, Y., Zeng, J., Han, C., & Yang, J. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70352
Kalyakulina, A., Yusipov, I., Botasheva, F., Bujlova, N., Вадимовна, З. Е., Franceschi, C., & Ivanchenko, M. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02195-w
Nakhebi, O. A. S. A., Șușan, R. M., Mihai, A., Bumbu, G. A., Mindru, F. M., Mornoş, C., & ENĂTESCU, V. R. (2026) · Diseases · doi:10.3390/diseases14070244
Bulsuhi, A. M. Y. A., Shehada, W., Suliman, S., Shah, J. Z., Kaddoura, R., Singh, K., Ali, N., Jama, A., JOHN, A., Babu, G. D. J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10232618/v1
Yunying, L., Yan, M., Ziqi, L., Zhang, X., Tan, X., Xu, S., Yuanhan, L., Lin, Q., Li, Y., & He, F. (2026) · Research Square · doi:10.21203/rs.3.rs-10185784/v1
Nylén, E., Khosla, S., Faselis, C. J., Pittaras, A. E., Aiken, M., & Kokkinos, P. F. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm48314
Romic, R., Cerovečki, V., Kermc, I., Adžić, Z. O., Petriček, G., Hanževački, M., Buljan, N., Hrabač, P., Samardžić, J., Reiner, Z., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145376
Lin, H., Qi, J., Jiang, Y., Yan, Y., Zhang, H., Zhang, X., Sun, J., Sun, M., Chen, W., Wang, C., et al. (2026) · SSM - Population Health · doi:10.1016/j.ssmph.2026.101946
“…(e.g., educational level and income), behavioral factors (e.g., alcohol consumption status, smoking status and physical activity status), health status (e.g., diabetes and hypertension), and body mass index (BMI) (D'Agostino RB et al., 2008; Samarasekera et al., 2023; Magnussen et al., 2023).”
Luo, Y., Dai, X., Chen, Z., Jiang, J., Liu, J., Fu, X., Wang, F., & Li, X. (2026) · Cardiovascular Toxicology · doi:10.1007/s12012-026-10154-3
Mackey, R., Bharucha, R., Monte, A., Spitznogle, A., Baindur, A. N., Sardar, D., Zonna, X. C., Gurusinghe, S., Beeler, E., Khan, A., et al. (2026) · medRxiv · doi:10.64898/2026.07.12.26357888
Three-Dimensional Cardiac Tissue Models for Pharmaceutical Research
Lu, X., Xie, B., Zhong, J., Xie, R., & Peng, W. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00217
Mahdi-akhgar, M., Hajizadeh, E., Baghestani, A. R., Khalili, D., & Khalkhali, H. R. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-02010-6
Fallahabadi, H., Ahmadi, F., Karamitanha, F., & Naser, M. (2026) · Discover Public Health · doi:10.1186/s12982-026-02607-5
Clinical Modifiers of Salt Sensitivity: A Meta-Regression and Risk Translation Study
Chen, S.-H., Yeh, C.-Y., Chiang-Lin, Y.-P., Huang, C., Chuang, S., Wu, C., Wh, P., Ma, Y., Liang, L., & Cheng, H. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.27410
Chmiel, J., Andreaggi, S., Kim, S., McNulty, I. A., Lee, H., BANNING, A. P., Bryniarski, K. L., Musiałek, P., & Jang, I. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102983
“1,24,25 Recently, an analysis of over 1.5 million participants showed that 5 modifiable RFs—dyslipidemia, hypertension, diabetes, obesity, and current smoking— accounted for over 50% of incident cardiovascular disease and about 20% of all-cause mortality.”
InfluentialMai, N.-D., Ullah, K., & Chung, W. (2026) · IEEE Transactions on Instrumentation and Measurement · doi:10.1109/tim.2026.3716478
Engineering etiology-aligned in vitro models of human vessels
Li, Q., Lin, J., Zou, W., You, J., Yu, S., Gao, Z., Du, H., Shen, X., Yin, J., Yang, H., et al. (2026) · Microsystems & Nanoengineering · doi:10.1038/s41378-026-01397-9
Colorado-Yohar, S. M., Cabrera-Castro, N., Huerta, J. M., Pérez-Martínez, A., Vaamonde-Martín, R. J., Gómez, J., Moreno-Núñez, M., & Chirlaque, M. (2026) · doi:10.67633/20.500.14784.26884.2026
Management von erhöhtem Blutdruck und Bluthochdruck: Risikoreduktion im Fokus
Schmieder, R. S., & Schunkert, H. (2026) · Herz · doi:10.1007/s00059-026-05385-7
Pastor-Cisneros, R., Henriques‐Neto, D., Pereira-Payo, D., Marques, A., Ferrari, G., de Lima, A. B., & Peralta, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1850784
Contact-Free Blood Pressure Estimation Based on Pulse Wave Velocity Using mmWave Signals
Liu, J., Wang, J., Gao, Q., Zhu, L., Chen, X., Pan, M., & Fang, Y. M. (2026) · IEEE Internet of Things Journal · doi:10.1109/jiot.2026.3717857
Zhang, J., Meng, X., Shin, H., & Choi, W. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1870365
“…and contemporary cardiovascular health frameworks highlight the importance of modifiable lifestyle domains — including sleep health, physical activity, diet, psychological stress, and substance use — as determinants of cardiovascular risk and potential contributors to SCD susceptibility (7, 8).”
Țocan, O. M., Pinte, L., Constantin, A. M., Băicuş, C., Schneider‐Kamp, A., & Oțelea, M. R. (2026) · Healthcare · doi:10.3390/healthcare14152330
Sex-Specific Considerations for Physical Activity, Diet, and Smoking
Gibbs, B. B., Kozai, A. C., & Davis, K. K. (2026) · Physiology in health and disease · doi:10.1007/978-3-032-26472-5_11
Cardiovascular Effects of Sex Hormones and Their Receptors
Molezini, L., Xia, W., & Khalil, R. A. (2026) · Physiology in health and disease · doi:10.1007/978-3-032-26472-5_6
Sayılı, U., Albayrak, B., Sak, K., Kaya, A., Uğurel, O. M., Çapar, M. U., Fenercioğlu, A. K., & Can, G. (2026) · Open Medicine · doi:10.1515/med-2026-1504
Hammoudeh, A., Aldalal’ah, M., Al-Malkawi, F., Haddad, E., Rizik, A., Shadeed, O., Sulaiman, S., Abughosh, M., Marouf, L., Khalil, Q. A., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1785553
Alsheyyab, J., Qtaish, N. A., AbuZamzam, H., Al-Saud, W. S., Al-Soud, A. S., Ahmed, K. A., Albekaen, N., Baker, M. B., Musa, R., Tawarh, B. Y. A., et al. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s583687
Bioelectrical Impedance in Cardiovascular Health
Baloda, S., Bouyer, B., Dubois, R., Thambo, J., Weynans, L., Bear, L. R., & Jalal, Z. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101650
Völker, L. A., & Ceccon, G. S. (2026) · Springer eBooks · doi:10.1007/978-3-476-06005-1_55-1
Yang, E., Sun, J., Dong, Y., Chang, C., Zhong, L., Tse, G., Cheung, B. M. Y., García-Zamora, S., & Koh, A. S.-M. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00450.2026
Watts, E. J. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107118
Akugizibwe, M., Namulundu, C. M., Tindyebwa, C. M., Nalubega, S., Namakoola, I., Kintu, I. S., Namara, A. A., Mirembe, D., Mugenyi, L., Ochanda, P. N., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10536082/v1
Associations Between the IL-23/IL-17A Cytokine Axis and Ambulatory Blood Pressure in Older AdultsPreprint
Gac, B. L., Katuvuidi, É. M., de la Colina, A. N., Badji, A., Lamarre-Cliché, M., Vallerand, D., & Girouard, H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743406
Xu, E., Lin, C., He, J., Tang, Y., Xiong, Y., Pu, Y., & Liu, T. (2026) · Scientific Reports · doi:10.1038/s41598-026-67008-9
Ismailova, M. A., Khudyakova, A. D., Garbuzova, E. V., Шрамко, В. С., Симонова, Г. И., Герасименко, О. Н., Shpagina, L. A., Dunicheva, O. V., Имаева, А. Э., Balanova, Y. А., et al. (2026) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2026-4830
Metadata
- Authors
- The Global Cardiovascular Risk Consortium
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- The Global Cardiovascular Risk Consortium
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-05
- Volume
- 389
- Issue
- 14
- Pages
- 1273-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC10589462
- OpenAlex
- W4386194106
- Cited by
- 909
- References
- 35
- Citations by year
- 2026: 285 · 2025: 359 · 2024: 242 · 2023: 23
- FWCI
- 47.54
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lithuanian University of Health Sciences (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Duo Research Archive (University of Oslo) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Union AFFECT-EU (Horizon 2020, No. 847770)
- German Center for Cardiovascular Research (not applicable)
- European Union MORGAM (Biomed, BMH4-CT98-3183)
- European Union GenomEUtwin (FP5, QLG2-CT-2002-01254)
- European Union ENGAGE (FP7, HEALTH-F4-2007-201413)
- European Union CHANCES (FP7, HEALTH-F3-2010-242244)
- European Union BiomarCaRE (FP7, HEALTH-F2-2011-278913)
- European Union euCanSHare (Horizon 2020, No. 825903)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- modifiable risk factors, cardiovascular disease, all-cause mortality, population attributable fraction, body mass index, systolic blood pressure, non-HDL cholesterol, smoking, diabetes mellitus, sex differences, regional variation, global cardiovascular risk, cohort studies, cardiovascular disease incidence, women's health
- MeSH terms
- Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk Factors, Smoking, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.